Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Tiotropium Respimat® in Cystic Fibrosis: Phase 3 and Pooled phase 2/3 randomized trials.

Tiotropium Respimat® in Cystic Fibrosis: Phase 3 and Pooled phase 2/3 randomized trials.

Resource Type

CF Research News

Authors

Felix Ratjen
Paul Koker
David E. Geller
Berengere Langellier-Cocteaux
Florence Le Maulf
Sabine Kattenbeck
Petra Moroni-Zentgraf
J Stuart Elborn
on behalf of the Tiotropium Cystic Fibrosis Study Group 2

References

J Cyst Fibros. 2015 Mar 25. pii: S1569-1993(15)00059-4. doi: 10.1016/j.jcf.2015.03.004

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Theme

Clinical Trials [3]

Keywords

Bronchodilator [4]
Respimat [5]
Tiotropium [6]

Date

Sunday, March 1, 2015

Featured resource article

No
Source URL:https://www.ecfs.eu/content/tiotropium-respimat%C2%AE-cystic-fibrosis-phase-3-and-pooled-phase-23-randomized-trials

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-14-00334R2_Ratjen_summary_Final_06062015.pdf [2] http://ac.els-cdn.com/S1569199315000594/1-s2.0-S1569199315000594-main.pdf?_tid=a8070af0-ffa1-11e4-83c3-00000aacb35f&acdnat=1432203230_58d14663190173fad8fbe66a42e96099 [3] https://www.ecfs.eu/research-article-themes/clinical-trials [4] https://www.ecfs.eu/research-article-keywords/bronchodilator [5] https://www.ecfs.eu/research-article-keywords/respimat [6] https://www.ecfs.eu/research-article-keywords/tiotropium